Page last updated: 2024-11-07

methylprednisolone acetate and Drug-Induced Stevens Johnson Syndrome

methylprednisolone acetate has been researched along with Drug-Induced Stevens Johnson Syndrome in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Research Excerpts

ExcerptRelevanceReference
" The use of systemic corticosteroids in the treatment of TEN is controversial because of a lack of randomized, controlled, prospective studies, and because the effects of steroid therapy vary depending on the dosage and time of its administration during the course of TEN."1.35Skin biopsies to assess response to systemic corticosteroid therapy in early-stage TEN: case report and review of the literature. ( Céspedes, YP; Nigra, TP; O'Donoghue, JM; Rockley, PF, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Donoghue, JM1
Céspedes, YP1
Rockley, PF1
Nigra, TP1

Other Studies

1 other study available for methylprednisolone acetate and Drug-Induced Stevens Johnson Syndrome

ArticleYear
Skin biopsies to assess response to systemic corticosteroid therapy in early-stage TEN: case report and review of the literature.
    Cutis, 2009, Volume: 84, Issue:3

    Topics: Adult; Anticonvulsants; Biopsy; Epilepsy, Tonic-Clonic; Female; Glucocorticoids; Humans; Methylpredn

2009